Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Obstructive Lung Diseases

Free Subscription 23.03.2026 2 Arch Dis Child 1 BMC Pediatr 2 Chest 1 Eur Respir J 3 J Allergy Clin Immunol 13 J Asthma 2 Pediatr Allergy Immunol 1 Pediatr Pulmonol 2 PLoS One 12 Respir Med 2 Respir Res 4 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Dis Child

1. PERIKLEOUS A, Lewis G, Bowen SJ, Pavord ID, et al
   Acceptability and feasibility of biomarkers of airway eosinophilic inflammation for the management of preschool wheeze: a qualitative study.
   Arch Dis Child. 2026;111:347-355.
   PubMed         Abstract available
   
   
2. MILANI GP, La Vecchia A, Fusco E, Mazzoni M, et al
   High-flow nasal cannula for lower respiratory infections in children under 2 years: a systematic review of indications.
   Arch Dis Child. 2026;111:326-333.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. SU X, Wang B, Wei X, Xue M, et al
   Family-based genome-wide association study for asthma among Han Chinese children.
   BMC Pediatr. 2026 Mar 17. doi: 10.1186/s12887-026-06685.
   PubMed        
   
   

   
   Chest

4. TANU F, Mortensen EM, Sacco SJ, Demirci D, et al
   Association of Inhaling Marijuana with Asthma Attacks: An Analysis of Nationally Representative Survey Data.
   Chest. 2026 Mar 16:S0012-3692(26)00324-7. doi: 10.1016/j.chest.2026.
   PubMed         Abstract available
   
   
5. RICHARDS C, Brunton AE, Choate R, Winthrop K, et al
   CFTR Mutations and Potential Associations with Increased Rates of Pulmonary Infections Among Patients from the US Bronchiectasis and NTM Research Registry.
   Chest. 2026 Mar 14:S0012-3692(26)00303-X. doi: 10.1016/j.chest.2026.
   PubMed        
   
   

   
   Eur Respir J

6. ROBERTSON NM, Sharma AK, Yang M, Das SK, et al
   A multi-country cohort study evaluating the prevalence, risk factors, lung function and clinical outcomes of chronic bronchitis in low- and middle-income countries.
   Eur Respir J. 2026;67:2501435.
   PubMed         Abstract available
   
   

   
   J Allergy Clin Immunol

7. ROY S, Sharma P
   Sex matters: IgE-associated nasal epithelial gene expression in asthma.
   J Allergy Clin Immunol. 2026 Mar 19:S0091-6749(26)00167.
   PubMed        
   
   
8. YU M, Ratia S, Kattel S, Nerkar R, et al
   Mast cell depletion and repopulation dynamics define briquilimab efficacy in a mouse model of allergic asthma.
   J Allergy Clin Immunol. 2026 Mar 16:S0091-6749(26)00132.
   PubMed        
   
   
9. MEIR AY, Li Y, Zhu Z, Espinola JA, et al
   Infancy IgE Methylation Score and Childhood Wheezing and Asthma; a Multi-Cohort Study.
   J Allergy Clin Immunol. 2026 Mar 11:S0091-6749(26)00185.
   PubMed         Abstract available
   
   

   
   J Asthma

10. BAPTIST AP, Lee JJ, Sabhapathy G, Carpenter L, et al
    A randomized trial of pocket cards to increase implementation of the 2020 NHLBI asthma guidelines.
    J Asthma. 2026 Mar 19:1-8. doi: 10.1080/02770903.2026.2644876.
    PubMed         Abstract available
    
    
11. WANG M, Jiang D
    Biologics in severe asthma: from precision phenotyping to clinical remission.
    J Asthma. 2026 Mar 18:1-12. doi: 10.1080/02770903.2026.2644878.
    PubMed         Abstract available
    
    
12. PIANIGIANI T, Dilroba A, Bergantini L, Bargagli E, et al
    Baseline dual elevation of fractional exhaled nitric oxide and blood eosinophils is associated with clinical remission in severe eosinophilic asthma treated with biologics: a real-world prospective study.
    J Asthma. 2026 Mar 17:1-9. doi: 10.1080/02770903.2026.2644882.
    PubMed         Abstract available
    
    
13. ZHANG S, Gluck A, Cone R, Priyev S, et al
    Content-Specific Engagement with a Mobile Asthma Education Application: A Real-World Analysis of ASTHMAXcel PRO.
    J Asthma. 2026 Mar 16:1-15. doi: 10.1080/02770903.2026.2644874.
    PubMed         Abstract available
    
    
14. IRAMAIN R, Castro-Rodriguez JA, Ortiz J, Jara A, et al
    The usefulness of the new SOBIstat-F(R) device in children with severe acute asthma attacks in the emergency department: A randomized clinical trial.
    J Asthma. 2026 Mar 16:1-12. doi: 10.1080/02770903.2026.2644872.
    PubMed         Abstract available
    
    
15. TIDEMANDSEN J, Meteran H, Gibson PG, Homoe AS, et al
    Lower Airway Dysfunction in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Associations with Asthma, ACQ5, and Inflammatory Markers.
    J Asthma. 2026 Mar 17:1-12. doi: 10.1080/02770903.2026.2645700.
    PubMed         Abstract available
    
    
16. YEGIN KATRAN Z, Argin O, Bulut I
    Primary and Steroid-Induced Antibody Deficiency in Severe Asthma: A Real-Life Analysis of a Well-Defined Biologic-Treated Cohort.
    J Asthma. 2026 Mar 17:1-11. doi: 10.1080/02770903.2026.2644881.
    PubMed         Abstract available
    
    
17. ROVSING AH, Hakansson KEJ, Hansen ESH, Meteran H, et al
    Impact of aging on high-dose inhaled corticosteroid use and specialist care management in patients with asthma - a Danish nationwide cohort study.
    J Asthma. 2026 Mar 17:1-13. doi: 10.1080/02770903.2026.2644873.
    PubMed         Abstract available
    
    
18. AW M, Lodhi S, Dibartolo M, Giangioppo S, et al
    Clinical validation of an electronic medical record-based asthma registry at a tertiary care center.
    J Asthma. 2026 Mar 18:1-12. doi: 10.1080/02770903.2026.2647917.
    PubMed         Abstract available
    
    
19. TAN DJ, Dharmage SC
    Mild Asthma - A Deceptive Danger.
    J Asthma. 2026 Mar 18:1-6. doi: 10.1080/02770903.2026.2647916.
    PubMed        
    
    
20. SINGH S, Trikala A, Hernandez E
    Pediatric Asthma Hospitalizations and Associated Factors in California.
    J Asthma. 2026 Mar 18:1-9. doi: 10.1080/02770903.2026.2647913.
    PubMed         Abstract available
    
    
21. WANG M, Zhou M, Yang Z, Liu L, et al
    The cloud-based integrated intelligent management system for childhood asthma affects the control level and quality of life of children with asthma.
    J Asthma. 2026 Mar 19:1-13. doi: 10.1080/02770903.2026.2644877.
    PubMed         Abstract available
    
    
22. AMBREEN F, Saxena R, Singh DK, Gupta S, et al
    Combined Effect of Pulmonary Rehabilitation and Vitamin D Supplementation on Pulmonary Function Tests in Asthma Patients.
    J Asthma. 2026 Mar 20:1-14. doi: 10.1080/02770903.2026.2647908.
    PubMed         Abstract available
    
    

    
    Pediatr Allergy Immunol

23. BALAJI A, Genuneit J, Eigenmann P, Park JS, et al
    Editorial comments on "low socioeconomic status, insulin resistance, asthma, and depression: A syndemic framework in Brazilian adolescents".
    Pediatr Allergy Immunol. 2026;37:e70317.
    PubMed        
    
    
24. ADELEKE SA, Lane R, Hardy P, Pappalardo AA, et al
    Leveraging educational data to advance equity in school-based asthma care.
    Pediatr Allergy Immunol. 2026;37:e70328.
    PubMed        
    
    

    
    Pediatr Pulmonol

25. ABBATE F, Biagini Y, Wiedemann F, Depietri G, et al
    Findings From Long-Term Follow-up in Children Hospitalized for Bronchiolitis in Pisa: Is It Time for a Standardized Protocol?
    Pediatr Pulmonol. 2026;61:e71563.
    PubMed         Abstract available
    
    

    
    PLoS One

26. YASMIN MF, Hosen MF, Basar MA, Rahman A, et al
    Gene expression and metadata based identification of key genes for lung cancer, COPD, and IPF using machine learning and statistical models.
    PLoS One. 2026;21:e0344666.
    PubMed         Abstract available
    
    
27. MCCLATCHEY K, Bertram D, Barat A, Delaney B, et al
    IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in UK primary care: An internal pilot for a cluster randomised controlled trial.
    PLoS One. 2026;21:e0336745.
    PubMed         Abstract available
    
    

    
    Respir Med

28. ZO S, Kim MJ, Kang MG, Kim SH, et al
    Bidirectional association between chronic periodontitis and bronchiectasis: A nationwide, population-based cohort study.
    Respir Med. 2026 Mar 18:108782. doi: 10.1016/j.rmed.2026.108782.
    PubMed         Abstract available
    
    
29. CALIS AG, Uzer F, Gurbuz AF, Erdem G, et al
    Long-term follow-up results of patients with combined pulmonary fibrosis and emphysema: A single-center experience.
    Respir Med. 2026;255:108780.
    PubMed         Abstract available
    
    
30. CALLE RUBIO M, Soler-Cataluna JJ, Lopez Campos JL, Alcazar Navarrete B, et al
    Clinical protocol for the use of biologic therapy in COPD.
    Respir Med. 2026;254:108718.
    PubMed         Abstract available
    
    
31. ROSENBERG V, Yahalom R, Livnat I, Yarden A, et al
    Changes over time in treatment patterns and health care resource utilization in patients with COPD: Real-World data from a large health maintenance organization.
    Respir Med. 2026;254:108719.
    PubMed         Abstract available
    
    
32. PEERLINGS DEM, Sprooten RTM, Wouters EFM, Lenaerts K, et al
    Gut integrity, systemic inflammation and exacerbations of COPD: the role of I-FABP.
    Respir Med. 2026;254:108737.
    PubMed         Abstract available
    
    
33. RESQUETI V, Torres-Castro R, Gimeno-Santos E, Lopes Cardoso N, et al
    Limitations of 6-minute walk test-based equations in predicting peak oxygen uptake and risk assessment in patients with pulmonary hypertension and COPD.
    Respir Med. 2026;254:108738.
    PubMed         Abstract available
    
    
34. XING Y, Li Y, Yang J, Yang J, et al
    Mapping the global landscape of biologics in allergic diseases: A bibliometric analysis.
    Respir Med. 2026;254:108734.
    PubMed         Abstract available
    
    
35. BRUSSELLE G, Bakakos P, Stolz D, Piraino A, et al
    BDP/FF/GB single-inhaler triple therapy in COPD: real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients.
    Respir Med. 2026;254:108743.
    PubMed         Abstract available
    
    
36. DE ZWART FL, Spruit MA, van 't Hul AJ
    A decade of treatable traits in patients with COPD: lessons learned about its application.
    Respir Med. 2026;254:108746.
    PubMed         Abstract available
    
    
37. ALSULAYYIM AS
    Respiratory muscle weakness in obstructive airway diseases, thoracic restrictive diseases, and neuromuscular diseases; understanding possible causes and treatments.
    Respir Med. 2026;254:108757.
    PubMed         Abstract available
    
    
38. STRATAN I, Covantsev S, Mathioudakis AG, Corlateanu A, et al
    COPD and kidney disease: not so far apart?
    Respir Med. 2026;254:108761.
    PubMed         Abstract available
    
    
39. DASGUPTA S, Ghosh N, Bhattacharya A, Mitra I, et al
    Lipid biomarkers for differentiating asthma-COPD overlap: Insights from LC-MS-based lipidomics.
    Respir Med. 2026;255:108779.
    PubMed         Abstract available
    
    

    
    Respir Res

40. TANABE N, Sato A, Maetani T, Sakamoto R, et al
    A novel quantitative method for CT assessment of bronchiectasis using AI-based airway segmentation and upper limits of normal airway caliber.
    Respir Res. 2026 Mar 16. doi: 10.1186/s12931-026-03629.
    PubMed        
    
    
41. SHAN X, Yan J, Han X, Zhu H, et al
    The association between long-term exposure to ozone and respiratory morbidity in Chinese adults: a nationwide cross-sectional study.
    Respir Res. 2026;27:138.
    PubMed         Abstract available
    
    

    
    Thorax

42. LEWIS A, Varkonyi-Sepp J, Healey N, Ainsworth B, et al
    An asthma-related anxiety intervention appropriate for the shift to digitalised care.
    Thorax. 2026 Mar 18:thorax-2026-224744. doi: 10.1136/thorax-2026-224744.
    PubMed        
    
    
43. MARSDEN P, Smith JA, Birring SS, Gruffydd-Jones K, et al
    Aligning management of chronic cough in asthma with BTS/NICE/SIGN guidance.
    Thorax. 2026 Mar 13:thorax-2025-224508. doi: 10.1136/thorax-2025-224508.
    PubMed        
    
    
44. ZHANG Y, Ye Z, Yang S, Zhang Y, et al
    Proteomics-based risk prediction and drug targets identification for chronic obstructive pulmonary disease.
    Thorax. 2026;81:311-319.
    PubMed         Abstract available
    
    
45. BROWN SE, Wootton S, Dale MT, Alison JA, et al
    Mobile health pulmonary rehabilitation (m-PR): a randomised controlled equivalence trial.
    Thorax. 2026;81:302-310.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum